Morgan Stanley Downgrades AstraZeneca (AZN) to Underweight
Tweet
Share
E-mailGet Alerts AZN Hot Sheet
Price: $92.77 --0%
Rating Summary:
19 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
19 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Morgan Stanley downgraded AstraZeneca (NYSE: AZN) from Overweight to Underweight.
For more ratings news on AstraZeneca click here and for the rating history of AstraZeneca click here.
Shares of AstraZeneca closed at $47.77 yesterday.
For more ratings news on AstraZeneca click here and for the rating history of AstraZeneca click here.
Shares of AstraZeneca closed at $47.77 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated statistically significant and clinically meaningful improvement in PFS as 1st-line treatment of patients with HER2-mutant advanced non-small ce
- Canaccord Downgrades Northern Star Resources (NST:AU) (NESRF) to Hold
- RBC Capital Downgrades Super Retail Group Ltd. (SUL:AU) to Sector Perform
Create E-mail Alert Related Categories
DowngradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
